Aberrant promoter hypermethylation in serum DNA from patients with silicosis

Shigeki Umemura, Nobukazu Fujimoto, Akio Hiraki, Kenichi Gemba, Nagio Takigawa, Keiichi Fujiwara, Masanori Fujii, Hiroshi Umemura, Mamoru Satoh, Masahiro Tabata, Hiroshi Ueoka, Katsuyuki Kiura, Takumi Kishimoto, Mitsune Tanimoto

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

It is well established that patients with silicosis are at high risk for lung cancer; however, it is difficult to detect lung cancer by chest radiography during follow-up treatment of patients with silicosis because of preexisting diffuse pulmonary shadows. The purpose of this study is to evaluate the usefulness of detection of serum DNA methylation for early detection of lung cancer in silicosis. Serum samples from healthy controls (n = 20) and silicosis patients with (n = 11) and without (n = 67) lung cancer were tested for aberrant hypermethylation at the promoters of the DNA repair gene O6 -methylguanine-DNA methyltransferase (MGMT), p16INK4a, ras association domain family 1A (RASSF1A), the apoptosis-related gene death-associated protein kinase (DAPK) and retinoic acid receptor β (RAR β) by methylation-specific polymerase chain reaction. Aberrant promoter methylation in at least one of five tumor suppressor genes was detected more frequently in the serum DNA of silicosis patients with lung cancer than in that of patients without it (P = 0.006). Furthermore, the odds ratio of having lung cancer was 9.77 (P = 0.009) for those silicosis patients with methylation of at least one gene. Extended exposure to silica (>30 years) was correlated with an increased methylation frequency (P = 0.017); however, methylation status did not correlate with age, smoking history or radiographic findings of silicosis. These results suggest that testing for aberrant promoter methylation of tumor suppressor genes using serum DNA may facilitate early detection of lung cancer in patients with silicosis.

Original languageEnglish
Pages (from-to)1845-1849
Number of pages5
JournalCarcinogenesis
Volume29
Issue number9
DOIs
Publication statusPublished - 2008

Fingerprint

Silicosis
Lung Neoplasms
Methylation
DNA
Serum
Tumor Suppressor Genes
Early Detection of Cancer
Death-Associated Protein Kinases
Genes
Retinoic Acid Receptors
Methyltransferases
DNA Methylation
Radiography
DNA Repair
Silicon Dioxide
Thorax
Smoking
History
Odds Ratio
Apoptosis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Umemura, S., Fujimoto, N., Hiraki, A., Gemba, K., Takigawa, N., Fujiwara, K., ... Tanimoto, M. (2008). Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Carcinogenesis, 29(9), 1845-1849. https://doi.org/10.1093/carcin/bgn169

Aberrant promoter hypermethylation in serum DNA from patients with silicosis. / Umemura, Shigeki; Fujimoto, Nobukazu; Hiraki, Akio; Gemba, Kenichi; Takigawa, Nagio; Fujiwara, Keiichi; Fujii, Masanori; Umemura, Hiroshi; Satoh, Mamoru; Tabata, Masahiro; Ueoka, Hiroshi; Kiura, Katsuyuki; Kishimoto, Takumi; Tanimoto, Mitsune.

In: Carcinogenesis, Vol. 29, No. 9, 2008, p. 1845-1849.

Research output: Contribution to journalArticle

Umemura, S, Fujimoto, N, Hiraki, A, Gemba, K, Takigawa, N, Fujiwara, K, Fujii, M, Umemura, H, Satoh, M, Tabata, M, Ueoka, H, Kiura, K, Kishimoto, T & Tanimoto, M 2008, 'Aberrant promoter hypermethylation in serum DNA from patients with silicosis', Carcinogenesis, vol. 29, no. 9, pp. 1845-1849. https://doi.org/10.1093/carcin/bgn169
Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K et al. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Carcinogenesis. 2008;29(9):1845-1849. https://doi.org/10.1093/carcin/bgn169
Umemura, Shigeki ; Fujimoto, Nobukazu ; Hiraki, Akio ; Gemba, Kenichi ; Takigawa, Nagio ; Fujiwara, Keiichi ; Fujii, Masanori ; Umemura, Hiroshi ; Satoh, Mamoru ; Tabata, Masahiro ; Ueoka, Hiroshi ; Kiura, Katsuyuki ; Kishimoto, Takumi ; Tanimoto, Mitsune. / Aberrant promoter hypermethylation in serum DNA from patients with silicosis. In: Carcinogenesis. 2008 ; Vol. 29, No. 9. pp. 1845-1849.
@article{2e876ec39c3448239a6f996b473f1fa8,
title = "Aberrant promoter hypermethylation in serum DNA from patients with silicosis",
abstract = "It is well established that patients with silicosis are at high risk for lung cancer; however, it is difficult to detect lung cancer by chest radiography during follow-up treatment of patients with silicosis because of preexisting diffuse pulmonary shadows. The purpose of this study is to evaluate the usefulness of detection of serum DNA methylation for early detection of lung cancer in silicosis. Serum samples from healthy controls (n = 20) and silicosis patients with (n = 11) and without (n = 67) lung cancer were tested for aberrant hypermethylation at the promoters of the DNA repair gene O6 -methylguanine-DNA methyltransferase (MGMT), p16INK4a, ras association domain family 1A (RASSF1A), the apoptosis-related gene death-associated protein kinase (DAPK) and retinoic acid receptor β (RAR β) by methylation-specific polymerase chain reaction. Aberrant promoter methylation in at least one of five tumor suppressor genes was detected more frequently in the serum DNA of silicosis patients with lung cancer than in that of patients without it (P = 0.006). Furthermore, the odds ratio of having lung cancer was 9.77 (P = 0.009) for those silicosis patients with methylation of at least one gene. Extended exposure to silica (>30 years) was correlated with an increased methylation frequency (P = 0.017); however, methylation status did not correlate with age, smoking history or radiographic findings of silicosis. These results suggest that testing for aberrant promoter methylation of tumor suppressor genes using serum DNA may facilitate early detection of lung cancer in patients with silicosis.",
author = "Shigeki Umemura and Nobukazu Fujimoto and Akio Hiraki and Kenichi Gemba and Nagio Takigawa and Keiichi Fujiwara and Masanori Fujii and Hiroshi Umemura and Mamoru Satoh and Masahiro Tabata and Hiroshi Ueoka and Katsuyuki Kiura and Takumi Kishimoto and Mitsune Tanimoto",
year = "2008",
doi = "10.1093/carcin/bgn169",
language = "English",
volume = "29",
pages = "1845--1849",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Aberrant promoter hypermethylation in serum DNA from patients with silicosis

AU - Umemura, Shigeki

AU - Fujimoto, Nobukazu

AU - Hiraki, Akio

AU - Gemba, Kenichi

AU - Takigawa, Nagio

AU - Fujiwara, Keiichi

AU - Fujii, Masanori

AU - Umemura, Hiroshi

AU - Satoh, Mamoru

AU - Tabata, Masahiro

AU - Ueoka, Hiroshi

AU - Kiura, Katsuyuki

AU - Kishimoto, Takumi

AU - Tanimoto, Mitsune

PY - 2008

Y1 - 2008

N2 - It is well established that patients with silicosis are at high risk for lung cancer; however, it is difficult to detect lung cancer by chest radiography during follow-up treatment of patients with silicosis because of preexisting diffuse pulmonary shadows. The purpose of this study is to evaluate the usefulness of detection of serum DNA methylation for early detection of lung cancer in silicosis. Serum samples from healthy controls (n = 20) and silicosis patients with (n = 11) and without (n = 67) lung cancer were tested for aberrant hypermethylation at the promoters of the DNA repair gene O6 -methylguanine-DNA methyltransferase (MGMT), p16INK4a, ras association domain family 1A (RASSF1A), the apoptosis-related gene death-associated protein kinase (DAPK) and retinoic acid receptor β (RAR β) by methylation-specific polymerase chain reaction. Aberrant promoter methylation in at least one of five tumor suppressor genes was detected more frequently in the serum DNA of silicosis patients with lung cancer than in that of patients without it (P = 0.006). Furthermore, the odds ratio of having lung cancer was 9.77 (P = 0.009) for those silicosis patients with methylation of at least one gene. Extended exposure to silica (>30 years) was correlated with an increased methylation frequency (P = 0.017); however, methylation status did not correlate with age, smoking history or radiographic findings of silicosis. These results suggest that testing for aberrant promoter methylation of tumor suppressor genes using serum DNA may facilitate early detection of lung cancer in patients with silicosis.

AB - It is well established that patients with silicosis are at high risk for lung cancer; however, it is difficult to detect lung cancer by chest radiography during follow-up treatment of patients with silicosis because of preexisting diffuse pulmonary shadows. The purpose of this study is to evaluate the usefulness of detection of serum DNA methylation for early detection of lung cancer in silicosis. Serum samples from healthy controls (n = 20) and silicosis patients with (n = 11) and without (n = 67) lung cancer were tested for aberrant hypermethylation at the promoters of the DNA repair gene O6 -methylguanine-DNA methyltransferase (MGMT), p16INK4a, ras association domain family 1A (RASSF1A), the apoptosis-related gene death-associated protein kinase (DAPK) and retinoic acid receptor β (RAR β) by methylation-specific polymerase chain reaction. Aberrant promoter methylation in at least one of five tumor suppressor genes was detected more frequently in the serum DNA of silicosis patients with lung cancer than in that of patients without it (P = 0.006). Furthermore, the odds ratio of having lung cancer was 9.77 (P = 0.009) for those silicosis patients with methylation of at least one gene. Extended exposure to silica (>30 years) was correlated with an increased methylation frequency (P = 0.017); however, methylation status did not correlate with age, smoking history or radiographic findings of silicosis. These results suggest that testing for aberrant promoter methylation of tumor suppressor genes using serum DNA may facilitate early detection of lung cancer in patients with silicosis.

UR - http://www.scopus.com/inward/record.url?scp=51849094489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849094489&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgn169

DO - 10.1093/carcin/bgn169

M3 - Article

VL - 29

SP - 1845

EP - 1849

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -